Display options
Cite
Imai H, Tajika A, Chen P, et al. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database Syst Rev. 2016;10:CD011170doi: 10.1002/14651858.CD011170.pub2.
Imai, H., Tajika, A., Chen, P., Pompoli, A., & Furukawa, T. A. (2016). Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. The Cochrane database of systematic reviews, 10CD011170. https://doi.org/10.1002/14651858.CD011170.pub2
Imai, Hissei, et al. "Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults." The Cochrane database of systematic reviews vol. 10 (2016): CD011170. doi: https://doi.org/10.1002/14651858.CD011170.pub2
Imai H, Tajika A, Chen P, Pompoli A, Furukawa TA. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database Syst Rev. 2016 Oct 12;10:CD011170. doi: 10.1002/14651858.CD011170.pub2. PMID: 27730622; PMCID: PMC6457876.
Copy Download .nbib Format: NLM
Share it on

Cochrane Database Syst Rev. 2016 Oct 12;10:CD011170. doi: 10.1002/14651858.CD011170.pub2.

Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.

The Cochrane database of systematic reviews

Hissei Imai, Aran Tajika, Peiyao Chen, Alessandro Pompoli, Toshi A Furukawa

Affiliations

  1. Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

PMID: 27730622 PMCID: PMC6457876 DOI: 10.1002/14651858.CD011170.pub2

Abstract

BACKGROUND: Panic disorder is common and deleterious to mental well-being. Psychological therapies and pharmacological interventions are both used as treatments for panic disorder with and without agoraphobia. However, there are no up-to-date reviews on the comparative efficacy and acceptability of the two treatment modalities, and such a review is necessary for improved treatment planning for this disorder.

OBJECTIVES: To assess the efficacy and acceptability of psychological therapies versus pharmacological interventions for panic disorder, with or without agoraphobia, in adults.

SEARCH METHODS: We searched the Cochrane Common Mental Disorders Group Specialised Register on 11 September 2015. This register contains reports of relevant randomised controlled trials from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1950 to present), Embase (1974 to present), and PsycINFO (1967 to present). We cross-checked reference lists of relevant papers and systematic reviews. We did not apply any restrictions on date, language, or publication status.

SELECTION CRITERIA: We included all randomised controlled trials comparing psychological therapies with pharmacological interventions for panic disorder with or without agoraphobia as diagnosed by operationalised criteria in adults.

DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and resolved any disagreements in consultation with a third review author. For dichotomous data, we calculated risk ratios (RR) with 95% confidence intervals (CI). We analysed continuous data using standardised mean differences (with 95% CI). We used the random-effects model throughout.

MAIN RESULTS: We included 16 studies with a total of 966 participants in the present review. Eight of the studies were conducted in Europe, four in the USA, two in the Middle East, and one in Southeast Asia.None of the studies reported long-term remission/response (long term being six months or longer from treatment commencement).There was no evidence of a difference between psychological therapies and selective serotonin reuptake inhibitors (SSRIs) in terms of short-term remission (RR 0.85, 95% CI 0.62 to 1.17; 6 studies; 334 participants) or short-term response (RR 0.97, 95% CI 0.51 to 1.86; 5 studies; 277 participants) (very low-quality evidence), and no evidence of a difference between psychological therapies and SSRIs in treatment acceptability as measured using dropouts for any reason (RR 1.33, 95% CI 0.80 to 2.22; 6 studies; 334 participants; low-quality evidence).There was no evidence of a difference between psychological therapies and tricyclic antidepressants in terms of short-term remission (RR 0.82, 95% CI 0.62 to 1.09; 3 studies; 229 participants), short-term response (RR 0.75, 95% CI 0.51 to 1.10; 4 studies; 270 participants), or dropouts for any reason (RR 0.83, 95% CI 0.53 to 1.30; 5 studies; 430 participants) (low-quality evidence).There was no evidence of a difference between psychological therapies and other antidepressants in terms of short-term remission (RR 0.90, 95% CI 0.48 to 1.67; 3 studies; 135 participants; very low-quality evidence) and evidence that psychological therapies did not significantly increase or decrease the short-term response over other antidepressants (RR 0.96, 95% CI 0.67 to 1.37; 3 studies; 128 participants) or dropouts for any reason (RR 1.55, 95% CI 0.91 to 2.65; 3 studies; 180 participants) (low-quality evidence).There was no evidence of a difference between psychological therapies and benzodiazepines in terms of short-term remission (RR 1.08, 95% CI 0.70 to 1.65; 3 studies; 95 participants), short-term response (RR 1.58, 95% CI 0.70 to 3.58; 2 studies; 69 participants), or dropouts for any reason (RR 1.12, 95% CI 0.54 to 2.36; 3 studies; 116 participants) (very low-quality evidence).There was no evidence of a difference between psychological therapies and either antidepressant alone or antidepressants plus benzodiazepines in terms of short-term remission (RR 0.86, 95% CI 0.71 to 1.05; 11 studies; 663 participants) and short-term response (RR 0.95, 95% CI 0.76 to 1.18; 12 studies; 800 participants) (low-quality evidence), and there was no evidence of a difference between psychological therapies and either antidepressants alone or antidepressants plus benzodiazepines in terms of treatment acceptability as measured by dropouts for any reason (RR 1.08, 95% CI 0.77 to 1.51; 13 studies; 909 participants; very low-quality evidence). The risk of selection bias and reporting bias was largely unclear. Preplanned subgroup and sensitivity analyses limited to trials with longer-term, quality-controlled, or individual psychological therapies suggested that antidepressants might be more effective than psychological therapies for some outcomes.There were no data to contribute to a comparison between psychological therapies and serotonin-norepinephrine reuptake inhibitors (SNRIs) and subsequent adverse effects.

AUTHORS' CONCLUSIONS: The evidence in this review was often imprecise. The superiority of either therapy over the other is uncertain due to the low and very low quality of the evidence with regard to short-term efficacy and treatment acceptability, and no data were available regarding adverse effects.The sensitivity analysis and investigation of the sources of heterogeneity indicated three possible influential factors: quality control of psychological therapies, the length of intervention, and the individual modality of psychological therapies.Future studies should examine the long-term effects after intervention or treatment continuation and should provide information on risk of bias, especially with regard to selection and reporting biases.

References

  1. J Psychosom Res. 1999 Feb;46(2):177-85 - PubMed
  2. Am J Psychiatry. 1999 May;156(5):675-82 - PubMed
  3. J Psychother Pract Res. 1999 Summer;8(3):234-42 - PubMed
  4. J Clin Psychiatry. 1999 Dec;60(12):831-8 - PubMed
  5. JAMA. 2000 May 17;283(19):2529-36 - PubMed
  6. Depress Anxiety. 2000;11(3):105-13 - PubMed
  7. Acta Psychiatr Scand Suppl. 2000;403:39-49 - PubMed
  8. Biol Psychiatry. 2000 Oct 15;48(8):830-43 - PubMed
  9. Med J Malaysia. 2000 Dec;55(4):402-8 - PubMed
  10. Am J Psychiatry. 2001 Dec;158(12):1993-8 - PubMed
  11. Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 2:II53-6 - PubMed
  12. Psychother Psychosom. 2002 Mar-Apr;71(2):85-9 - PubMed
  13. Int J Epidemiol. 2002 Feb;31(1):72-6 - PubMed
  14. J Consult Clin Psychol. 2002 Apr;70(2):275-87 - PubMed
  15. Lancet. 2002 Jun 29;359(9325):2253-4 - PubMed
  16. Depress Anxiety. 2002;16(4):162-71 - PubMed
  17. J Med Ethics. 2003 Aug;29(4):238-42 - PubMed
  18. BMJ. 2003 Sep 6;327(7414):557-60 - PubMed
  19. Br J Med Psychol. 1959;32(1):50-5 - PubMed
  20. J Consult Clin Psychol. 1992 Oct;60(5):664-9; discussion 670-7 - PubMed
  21. Behav Res Ther. 2003 Dec;41(12):1427-49 - PubMed
  22. Arch Gen Psychiatry. 2004 Jan;61(1):34-41 - PubMed
  23. Ann Clin Psychiatry. 2004 Jan-Mar;16(1):41-6 - PubMed
  24. CMAJ. 1992 Sep 15;147(6):878-83 - PubMed
  25. Am J Psychiatry. 2004 Aug;161(8):1485-7 - PubMed
  26. Neuro Endocrinol Lett. 2004 Oct;25(5):340-8 - PubMed
  27. Int Clin Psychopharmacol. 2005 Jan;20(1):49-52 - PubMed
  28. Acta Psychiatr Scand. 1992 Mar;85(3):201-6 - PubMed
  29. Psychol Med. 2004 Nov;34(8):1385-94 - PubMed
  30. Med Care. 1992 Jun;30(6):473-83 - PubMed
  31. J Consult Clin Psychol. 2005 Jun;73(3):506-14 - PubMed
  32. J Affect Disord. 2005 Sep;88(1):27-45 - PubMed
  33. Acta Psychiatr Scand. 2005 Sep;112(3):224-32 - PubMed
  34. Br J Psychiatry. 2005 Oct;187:352-9 - PubMed
  35. Arch Gen Psychiatry. 2005 Nov;62(11):1249-57 - PubMed
  36. Am J Geriatr Psychiatry. 2006 Mar;14(3):255-63 - PubMed
  37. Arch Gen Psychiatry. 2006 Apr;63(4):415-24 - PubMed
  38. J Clin Psychiatry. 2006 Mar;67(3):363-74 - PubMed
  39. Depress Anxiety. 2006;23(5):312-24 - PubMed
  40. J Consult Clin Psychol. 2006 Dec;74(6):1173-9 - PubMed
  41. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004364 - PubMed
  42. Am J Psychiatry. 2007 Feb;164(2):265-72 - PubMed
  43. Psychother Psychosom. 2007;76(3):154-61 - PubMed
  44. J Consult Clin Psychol. 2007 Jun;75(3):374-9 - PubMed
  45. J Clin Psychiatry. 2007 Jul;68(7):1038-44 - PubMed
  46. Behav Res Ther. 2008 Mar;46(3):296-321 - PubMed
  47. Acta Psychiatr Scand. 2008 Apr;117(4):260-70 - PubMed
  48. Am J Psychiatry. 2008 Apr;165(4):445-52 - PubMed
  49. Br J Psychiatry. 2008 May;192(5):362-7 - PubMed
  50. J Consult Clin Psychol. 2009 Apr;77(2):203-11 - PubMed
  51. PLoS Med. 2009 Jul 21;6(7):e1000097 - PubMed
  52. Clin Psychol Rev. 2010 Feb;30(1):37-50 - PubMed
  53. Acta Psychiatr Scand. 2010 Jul;122(1):11-9 - PubMed
  54. Psychol Med. 2010 Dec;40(12):2059-68 - PubMed
  55. J Clin Psychiatry. 2010 Jul;71(7):839-54 - PubMed
  56. Int J Psychophysiol. 2010 Oct;78(1):68-79 - PubMed
  57. J Clin Psychiatry. 2011 Jan;72(1):43-50 - PubMed
  58. J Nerv Ment Dis. 2010 Sep;198(9):647-52 - PubMed
  59. J Clin Psychiatry. 2011 Jan;72(1):98-113 - PubMed
  60. Expert Opin Pharmacother. 2011 Jun;12(9):1419-28 - PubMed
  61. Int J Geriatr Psychiatry. 2012 Feb;27(2):146-50 - PubMed
  62. Curr Opin Neurobiol. 2011 Dec;21(6):858-65 - PubMed
  63. Psychother Res. 2011 Nov;21(6):670-84 - PubMed
  64. Health Educ Behav. 2012 Aug;39(4):474-85 - PubMed
  65. Clin Psychol Psychother. 2013 Jul-Aug;20(4):286-96 - PubMed
  66. Curr Opin Psychiatry. 2012 Nov;25(6):522-8 - PubMed
  67. J Clin Psychiatry. 2013 May;74(5):482-91 - PubMed
  68. J Consult Clin Psychol. 1990 Feb;58(1):77-84 - PubMed
  69. Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033 - PubMed
  70. J Affect Disord. 2013 Sep 5;150(2):313-9 - PubMed
  71. Cochrane Database Syst Rev. 2013 Jun 03;(6):CD004690 - PubMed
  72. J Psychopharmacol. 2014 May;28(5):403-39 - PubMed
  73. Br J Psychiatry. 2015 Aug;207(2):115-22 - PubMed
  74. Arch Gen Psychiatry. 1989 Nov;46(11):984-92 - PubMed
  75. Behav Ther. 2016 Nov;47(6):869-885 - PubMed
  76. Lancet. 1988 Jul 30;2(8605):235-40 - PubMed
  77. J Consult Clin Psychol. 1988 Dec;56(6):877-84 - PubMed
  78. J Consult Clin Psychol. 1988 Dec;56(6):893-7 - PubMed
  79. Behav Res Ther. 1986;24(1):1-8 - PubMed
  80. Behav Res Ther. 1985;23(1):35-44 - PubMed
  81. Arch Gen Psychiatry. 1972 Jan;26(1):57-63 - PubMed
  82. Behav Res Ther. 1979;17(3):263-7 - PubMed
  83. Annu Rev Physiol. 1981;43:121-35 - PubMed
  84. Arch Gen Psychiatry. 1984 Mar;41(3):238-45 - PubMed
  85. J Consult Clin Psychol. 1984 Dec;52(6):1090-7 - PubMed
  86. Arch Gen Psychiatry. 1978 Jun;35(6):773-82 - PubMed
  87. J Clin Psychiatry. 1982 Oct;43(10):423-5 - PubMed
  88. Int Clin Psychopharmacol. 1995 Jun;10(2):73-81 - PubMed
  89. Br J Psychiatry. 1994 Jun;164(6):759-69 - PubMed
  90. J Affect Disord. 1994 Apr;30(4):233-41 - PubMed
  91. J Consult Clin Psychol. 1993 Apr;61(2):317-26 - PubMed
  92. Am J Psychiatry. 1994 Mar;151(3):413-20 - PubMed
  93. Arch Gen Psychiatry. 1993 Jan;50(1):44-50 - PubMed
  94. Br J Psychiatry. 1993 Feb;162:219-26 - PubMed
  95. Arch Gen Psychiatry. 1993 Apr;50(4):306-17 - PubMed
  96. Ann Clin Psychiatry. 1995 Dec;7(4):181-8 - PubMed
  97. Br J Psychiatry. 1996 Jul;169(1):93-7 - PubMed
  98. BMJ. 1996 Nov 9;313(7066):1200 - PubMed
  99. Br J Gen Pract. 1997 Mar;47(416):150-5 - PubMed
  100. Am J Psychiatry. 1997 Nov;154(11):1571-5 - PubMed
  101. Arch Gen Psychiatry. 1976 Jun;33(6):766-71 - PubMed
  102. Arch Gen Psychiatry. 1998 Aug;55(8):715-20 - PubMed
  103. Depress Anxiety. 1998;8(1):14-20 - PubMed
  104. Psychol Med. 1998 Sep;28(5):1149-57 - PubMed
  105. Am J Psychiatry. 1998 Nov;155(11):1570-7 - PubMed
  106. Soc Psychiatry Psychiatr Epidemiol. 1998 Dec;33(12):587-95 - PubMed

Substances

MeSH terms

Publication Types